HAROLD O. CONN, M.D.
It is no easy task to pick one's way from truth to truth through besetting errors.
PETER MERE LATHAM
The final report of the Boston Inter-Hospital Liver Group (BILG) study of prophylactic portacaval shunt in this issue of the ANNALS (1) is a landmark in clinical investigation. It illustrates a number of new and necessary trends in use by investigators who study patients.
First, this project was designed to come to grips with one of the most controversial problems of medicine. It does not concern itself with peripheral aspects of portal hypertension but faces directly the core issues: Can portal
CONN HO. Prophylactic Portacaval Shunts. Ann Intern Med. ;70:859–864. doi: 10.7326/0003-4819-70-4-859
Download citation file:
Published: Ann Intern Med. 1969;70(4):859-864.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use